Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Neoplasm Metastasis 1

Interventions

Cisplatin 1041Cyclophosphamide 974Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 760Paclitaxel 740Docetaxel 734Oxaliplatin 706Capecitabine 650Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 327Trastuzumab 324Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 279Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × irosustat × Clear all
NCT01662726 2016-03-14

IPET

Imperial College London

Phase 2 Terminated
13 enrolled
Breast

Breast Neoplasms

NCT01785992 2015-03-24

IRIS

Imperial College London

Phase 2 Completed
27 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡